Baker McKenzie advised ATB Therapeutics SA on the deal.ATB Therapeutics SA, a Belgian next-generation antibody company, completed a EUR 54 million Series A financing. The financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
